Bioclinica, Inc. (BIOC) Tops Q4 EPS by 1c

February 6, 2013 7:17 AM EST
Get Alerts BIOC Hot Sheet
Trade BIOC Now!
Join SI Premium – FREE
Bioclinica, Inc. (NASDAQ: BIOC) reported Q4 EPS of $0.10, $0.01 better than the analyst estimate of $0.09. Revenue for the quarter came in at $27.61 million versus the consensus estimate of $24.62 million.

For earnings history and earnings-related data on Bioclinica, Inc. (BIOC) click here.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories


Related Entities


Add Your Comment